Labcorp Holdings Inc. LH

309.64 0.69 0.22% as of 25 Sep
Market cap
$21.9B
P/E
25.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Labcorp Holdings Inc. (LH) EV/Sales

As of 25 September 2026, Labcorp Holdings Inc. (LH) trades at a EV/Sales of 2.2×. Over the past ten years it has ranged from 1.3× (March 2020) to 2.5× (April 2015); the current reading is higher than 96% of that period. That is below the Diagnostics & Research industry median of 5.7× and below the Healthcare sector median of 3.6×.

EV/Sales, daily

Annual

Period EV/Sales Change
FY2025 1.9× 2.31%
FY2024 1.9× (9.23%)
FY2023 2.1× 2.07%
FY2022 2.0× (12.73%)
FY2021 2.3× 48.23%
FY2020 1.6× (11.79%)
FY2019 1.8× 20.31%
FY2018 1.5× (25.50%)
FY2017 2.0× 15.94%
FY2016 1.7× (6.17%)

Quarterly

Period EV/Sales Change
Jun 2026 2.1× 4.84%
Mar 2026 2.0× 3.76%
Dec 2025 1.9× (11.06%)
Sep 2025 2.1× 5.12%
42 more quarters

Against its own ten years

Low 1.3× High 2.5×
Ten-year median 1.9×
Current reading's percentile 96

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on LH